Bromocriptine Mesylate Capsule
Product Images NDC 68382-110

2 FDA label images from Zydus Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bromocriptine Mesylate (NDC 68382-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (98e43e82 81ff 465b A27d F620b182705c 01)

Image (98e43e82 81ff 465b A27d F620b182705c 01)
Chemical structure of bromocriptine mesylate, a complex molecule showing multiple rings, including a bromine (Br) atom, and functional groups indicating its mesylate salt form (CH3SO3H).*
FDA Label Image

2 (98e43e82 81ff 465b A27d F620b182705c 02)

2 (98e43e82 81ff 465b A27d F620b182705c 02)
Label for Bromocriptine Mesylate Capsules, USP 5 mg by Zydus Pharmaceuticals USA Inc. The label includes the NDC 68382-110-01, states the package contains 100 capsules for oral use, and notes the product is prescription only. Storage and manufacturing information by Zydus Lifesciences Ltd. is also provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.